Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Valuation
-
$213,000,000
Company Info
- Founding Year
- 2007
- Traction
- Strong investor support demonstrated by raising CHF 90 million through the IPO.
- Organizations Involved
- GSK
- Founders
- Marc Gitzinger
- Company Description
- BioVersys is a Basel-based biotech company focused on combating multidrug-resistant bacteria, developing key products such as BV100 for pneumonia and bloodstream infections, and alpibectir for tuberculosis in collaboration with GSK.
- Market
- Pharmaceuticals, specifically antimicrobial resistance treatments
- Location
-
Basel,
Switzerland
Links